Antioxidant intake from diet and supplements and elevated serum C-reactive protein and plasma homocysteine concentrations in US adults: A cross-sectional study

Public Health Nutrition

Volumn 14, Issue 11, 2011, Pages 2055-2064

  Floegel, Anna ^a,b   Chung, Sang Jin ^c   Von Ruesten, Anne ^b   Yang, Meng ^a   Chung, Chin E ^d   Song, Won O ^e   Koo, Sung I ^a   Pischon, Tobias ^b   Chun, Ock K ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^c Kookmin University   (South Korea)

^d Ansan University   (South Korea)

^e Michigan State University   (United States)

Author keywords

Antioxidants; C reactive protein; Carotenes; Diet; Flavonoids; Homocysteine; Selenium; Supplements; Vitamin C; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; C REACTIVE PROTEIN; CAROTENOID; FLAVONOID; HOMOCYSTEINE; SELENIUM; VITAMIN;

ADULT; ARTICLE; BLOOD; CROSS-SECTIONAL STUDY; DIET; DIET SUPPLEMENTATION; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUTRITION; STATISTICAL MODEL; UNITED STATES;

ADULT; ANTIOXIDANTS; ASCORBIC ACID; C-REACTIVE PROTEIN; CAROTENOIDS; CROSS-SECTIONAL STUDIES; DIET; DIETARY SUPPLEMENTS; FEMALE; FLAVONOIDS; HOMOCYSTEINE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUTRITION SURVEYS; SELENIUM; UNITED STATES; VITAMIN E; VITAMINS;

EID: 84857076457     PISSN: 13689800     EISSN: 14752727     Source Type: Journal    
DOI: 10.1017/S1368980011000395     Document Type: Review

References (57)

1. Lloyd-Jones D, Adams RJ, Brown TM et al. (2010) Heart disease and stroke statistics - 2010 update: a report from the American Heart Association. Circulation 121, 948-954.
2. Mora S, Musunuru K & Blumenthal RS (2009) The clinical utility of high-sensitivity C-reactive protein in cardiovascular disease and the potential implication of JUPITER on current practice guidelines. Clin Chem 55, 219-228.
3. Stanger O, Herrmann W, Pietrzik K et al. (2003) DACHLIGA homocystein (German, Austrian and Swiss Homocysteine Society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Clin Chem Lab Med 41, 1392-1403.
4. Buckley DI, Fu R, Freeman M et al. (2009) C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the US Preventive Services Task Force. Ann Intern Med 151, 483-495.
5. Ford ES, Smith SJ, Stroup DF et al. (2002) Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies. Int J Epidemiol 31, 59-70.
6. Pepys MB & Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Invest 111, 1805-1812.
7. Nanri A, Moore MA & Kono S (2007) Impact of C-reactive protein on disease risk and its relation to dietary factors. Asian Pac J Cancer Prev 8, 167-177.
8. Cavicchia PP, Steck SE, Hurley TG et al. (2009) A new dietary inflammatory index predicts interval changes in serum high-sensitivity C-reactive protein. J Nutr 139, 2365-2372.
9. di Giuseppe R, Di Castelnuovo A, Centritto F et al. (2008) Regular consumption of dark chocolate is associated with low serum concentrations of C-reactive protein in a healthy Italian population. J Nutr 138, 1939-1945.
10. Esmaillzadeh A, Kimiagar M, Mehrabi Y et al. (2006) Fruit and vegetable intakes, C-reactive protein, and the metabolic syndrome. Am J Clin Nutr 84, 1489-1497.
11. Hung H-C, Joshipura KJ, Jiang R et al. (2004) Fruit and vegetable intake and risk of major chronic disease. J Natl Cancer Inst 96, 1577-1584.
12. Nanri A, Yoshida D, Yamaji T et al. (2008) Dietary patterns and C-reactive protein in Japanese men and women. Am J Clin Nutr 87, 1488-1496.
13. Conner EM & Grisham MB (1996) Inflammation, free radicals, and antioxidants. Nutrition 12, 274-277.
14. Davies KJ (2000) Oxidative stress, antioxidant defenses, and damage removal, repair, and replacement systems. IUBMB Life 50, 279-289.
15. Kritharides L & Stocker R (2002) The use of antioxidant supplements in coronary heart disease. Atherosclerosis 164, 211-219.
16. Murphy KJ, Chronopoulos AK, Singh I et al. (2003) Dietary flavanols and procyanidin oligomers from cocoa (Theobroma cacao) inhibit platelet function. Am J Clin Nutr 77, 1466-1473.
17. Widlansky ME, Duffy SJ, Hamburg NM et al. (2005) Effects of black tea consumption on plasma catechins and markers of oxidative stress and inflammation in patients with coronary artery disease. Free Radic Biol Med 38, 499-506.
18. Steptoe A, Gibson EL, Vuononvirta R et al. (2007) The effects of chronic tea intake on platelet activation and inflammation: a double-blind placebo controlled trial. Atherosclerosis 193, 277-282.
19. De Bacquer D, Clays E, Delanghe J et al. (2006) Epidemiological evidence for an association between habitual tea consumption and markers of chronic inflammation. Atherosclerosis 189, 428-435.
20. Fukino Y, Shimbo M, Aoki N et al. (2005) Randomized controlled trial for an effect of green tea consumption on insulin resistance and inflammation markers. J Nutr Sci Vitaminol (Tokyo) 51, 335-342.
21. Patrick L (2000) Beta-carotene: the controversy continues. Altern Med Rev 5, 530-545.
22. Salonen RM, Nyyssonen K, Kaikkonen J et al. (2003) Sixyear effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation 107, 947-953.
23. Scheurig AC, Thorand B, Fischer B et al. (2008) Association between the intake of vitamins and trace elements from supplements and C-reactive protein: results of the MONICA/ KORA Augsburg study. Eur J Clin Nutr 62, 127-137.
24. Boekholdt SM, Meuwese MC, Day NE et al. (2006) Plasma concentrations of ascorbic acid and C-reactive protein, and risk of future coronary artery disease, in apparently healthy men and women: the EPIC-Norfolk prospective population study. Br J Nutr 96, 516-522.
25. Ford ES, Liu S, Mannino DM et al. (2003) C-reactive protein concentration and concentrations of blood vitamins, carotenoids, and selenium among United States adults. Eur J Clin Nutr 57, 1157-1163.
26. Chun OK, Chung SJ, Claycombe KJ et al. (2008) Serum Creactive protein concentrations are inversely associated with dietary flavonoid intake in US adults. J Nutr 138, 753-760.
27. Chun OK, Floegel A, Chung SJ et al. (2010) Estimation of antioxidant intakes from diet and supplements in US adults. J Nutr 140, 317-324.
28. National Center for Health Statistics (2002) National Health and Nutrition Examination Survey, 1999-2000 Data Files. Hyattsville, MD: Centers for Disease Control and Prevention.
29. National Center for Health Statistics (2004) National Health and Nutrition Examination Survey, 2001-2002 Data Files. Hyattsville, MD: Centers for Disease Control and Prevention.
30. Botman S, Moore T, Moriarity C et al. (2000) Design and estimation for the national health interview survey, 1995-2004. Vital Health Stat 2 130, 1-31.
31. Chun O, Chung S & Song W (2007) Estimated dietary flavonoid intakes and major food sources of US adults. J Nutr 137, 1244-1252.
32. Agricultural Research Service (2003) Database for the Flavonoid Content of Selected Foods. Beltsville, MD: USDA.
33. Agricultural Research Service (2002) USDA-Iowa State University Database on the Isoflavone Content of Foods, Release 1.3. Beltsville, MD: USDA.
34. Institute of Medicine (2000) Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: National Academies Press.
35. National Center for Health Statistics, US Department of Health and Human Services, Centers for Disease Control and Prevention (2001) National Health and Nutrition Examination Survey Laboratory Procedure Manual. Hyattsville, MD: NCHS; available at http://www.cdc.gov/ nchs/nhanes/nhanes2001-2002/lab01-02.htm
36. Jacques PF, Selhub J, Bostom AG et al. (1999) The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 340, 1449-1454.
37. Pfeiffer CM, Caudill SP, Gunter EW et al. (2005) Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999-2000. Am J Clin Nutr 82, 442-450.
38. Haan MN, Miller JW, Aiello AE et al. (2007) Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging. Am J Clin Nutr 85, 511-517.
39. Pearson TA, Mensah GA, Alexander RWet al. (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107, 499-511.
40. Blake GJ, Rifai N, Buring JE et al. (2003) Blood pressure, C-reactive protein, and risk of future cardiovascular events. Circulation 108, 2993-2999.
41. Brighenti F, Valtuena S, Pellegrini N et al. (2005) Total antioxidant capacity of the diet is inversely and independently related to plasma concentration of high-sensitivity C-reactive protein in adult Italian subjects. Br J Nutr 93, 619-625.
42. Paolisso G, Esposito R, D'Alessio MA et al. (1999) Primary and secondary prevention of atherosclerosis: is there a role for antioxidants? Diabetes Metab 25, 298-306.
43. Navarro-Alarcon M & Cabrera-Vique C (2008) Selenium in food and the human body: a review. Sci Total Environ 400, 115-141.
44. Bostom AG, Shemin D, Lapane KL et al. (1996) Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients. Atherosclerosis 123, 193-202.
45. Guo H, Chi J, Xing Y et al. (2009) Influence of folic acid on plasma homocysteine levels & arterial endothelial function in patients with unstable angina. Indian J Med Res 129, 279-284.
46. Seddon JM, Gensler G, Klein ML et al. (2006) C-reactive protein and homocysteine are associated with dietary and behavioral risk factors for age-related macular degeneration. Nutrition 22, 441-443.
47. Maxwell SR (2000) Coronary artery disease - free radical damage, antioxidant protection and the role of homocysteine. Basic Res Cardiol 95, Suppl. 1, SI65-SI71.
48. Joseph J, Joseph L, Devi S et al. (2008) Effect of anti-oxidant treatment on hyperhomocysteinemia-induced myocardial fibrosis and diastolic dysfunction. J Heart Lung Transplant 27, 1237-1241.
49. Atamer A, Kocyigit Y, Ecder SA et al. (2008) Effect of oxidative stress on antioxidant enzyme activities, homocysteine and lipoproteins in chronic kidney disease. J Nephrol 21, 924-930.
50. Kerkeni M, Added F, Ben Farhat M et al. (2008) Hyperhomocysteinaemia and parameters of antioxidative defence in Tunisian patients with coronary heart disease. Ann Clin Biochem 45, 193-198.
51. Burk RF & Levander OA (2006) Selenium. In Modern Nutrition in Health and Disease, 10th ed., pp. 312-325 [ME Shils, M Shike, AC Ross et al., editors]. Baltimore, MD: Lippincott Williams and Wilkins.
52. Ockene IS, Matthews CE, Rifai N et al. (2001) Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin Chem 47, 444-450.
53. Scirica BM & Morrow DA (2006) Is C-reactive protein an innocent bystander or proatherogenic culprit' The verdict is still out. Circulation 113, 2128-2134.
54. Ridker PM (2003) Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107, 363-369.
55. Rana JS, Cote M, Despres JP et al. (2009) Inflammatory biomarkers and the prediction of coronary events among people at intermediate risk: the EPIC-Norfolk prospective population study. Heart 95, 1682-1687.
56. Shah T, Casas JP, Cooper JA et al. (2009) Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts. Int J Epidemiol 38, 217-231.
57. Byers T (1992) Nutrition monitoring and surveillance. In Nutritional Epidemiology, 2nd ed., pp. 347-356 [W Willett, editor]. New York: Oxford University Press.